Results 201 to 210 of about 249,373 (343)

Meeting INR Targets for the Left Ventricular Assist Device Patient

, 2013
S.A. Schaefer, Anita Schmitt, Jason Bjelkengren, Scot Lewey, BethAnn McLaughlin, D. Sato, S. Puhlman, Sung Woon Pyo, R. Oberst, Erin Lawrence, P.D. Hester, Charles E. Sparks, P.J. Kaley, Steve M. Blevins, David Sandler, Timothy B. Icenogle   +15 more
openalex   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source

Left Ventricular Assist Device Destination Therapy: A Journey to Home and Beyond. [PDF]

JACC Case Rep
Munir MZ, Galicia-Castillo MC, Achitoov M, Yehya A.   +3 more
europepmc   +1 more source

Ventricular Assist Device Program Gains Prestigious Accreditation [PDF]

, 2009

core   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Rationale and design of the randomized 'early ventricular assist device'-Trial (VAD-DZHK3). [PDF]

ESC Heart Fail
Knosalla C, Färber G, Rieth AJ, Wachter R, Placzek M, Albert W, Hasenfuß G, Falk V, Friede T, VAD‐DZHK3 Investigators.   +9 more
europepmc   +1 more source

A Case Report of Ventricular Fibrillation Supported by Left Ventricular Assist Device For Hours. [PDF]

Ersin Doğanözü, Özgür Ersoy, Atilla Sezgin, Bülent Özin   +3 more
openalex   +1 more source

Simulation-Based Mastery Learning Improves Patient and Caregiver Ventricular Assist Device Self-Care Skills [PDF]

, 2019
Jeffrey H. Barsuk, Jane E. Wilcox, Elaine Cohen, Rebecca Harap, Kerry B. Shanklin, Kathleen L. Grady, Jane S. Kim, Gretchen P. Nonog, Lauren E. Schulze, Alison M. Jirak, Diane B. Wayne, Kenzie A. Cameron   +11 more
openalex   +1 more source

Prospective trial of a pediatric ventricular assist device [PDF]

, 2012
Canter, Charles E, et al,
core   +2 more sources

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source